CANGIALOSI LORETTA V 4

4 · PFIZER INC · Filed Mar 1, 2019

Form 4

Period: 2019-02-27

Sr. Vice President, Controller

Transactions

Award
Common Stock
2019-02-28+3,482→ 108,607 total
Exercise/Conversion
Stock Appreciation Rights
2019-02-27−25,729→ 0 total
Exercise: $32.23From: 2019-02-27Exp: 2019-02-27→ Common Stock (25,729 underlying)
Tax Payment
Common Stock
2019-02-27$42.93/sh−4,819$206,880→ 121,015 total
Award
Stock Appreciation Rights
2019-02-28+15,211→ 15,211 total
Exercise: $43.35From: 2026-02-28Exp: 2026-02-28→ Common Stock (15,211 underlying)
Exercise/Conversion
Common Stock
2019-02-27$32.23/sh+25,729$829,246→ 121,743 total
Award
Common Stock
2019-02-27+8,017→ 129,760 total
Tax Payment
Common Stock
2019-02-27$42.93/sh−3,926$168,543→ 125,834 total
Tax Payment
Common Stock
2019-02-27$42.31/sh−15,890$672,306→ 105,125 total
Award
Stock Appreciation Rights
2019-02-28+18,050→ 18,050 total
Exercise: $43.35From: 2024-02-28Exp: 2024-02-28→ Common Stock (18,050 underlying)

Holdings

Footnotes (9)

[F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
[F2]The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
[F3]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
[F4]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
[F5]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
[F6]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
[F7]The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
[F8]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
[F9]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Documents

1 file